Hyperinsulinemia. A link between hypertension obesity and glucose intolerance

M Modan, H Halkin, S Almog, A Lusky, A Eshkol, M Shefi, A Shitrit, Z Fuchs, M Modan, H Halkin, S Almog, A Lusky, A Eshkol, M Shefi, A Shitrit, Z Fuchs

Abstract

Hypertension and glucose intolerance, determined in a random population sample (n = 2,475), showed a highly significant (P less than 0.001) association from the mildest levels of both conditions, independent of the confounding effects of age, sex, obesity, and antihypertensive medications. Summary rate ratios for hypertension were 1.48 (1.18-1.87) in abnormal tolerance and 2.26 (1.69-2.84) in diabetes compared with normal tolerance. Altogether, 83.4% of the hypertensives were either glucose-intolerant or obese--both established insulin-resistant conditions. Fasting and post-load insulin levels in a representative subgroup (n = 1,241) were significantly elevated in hypertension independent of obesity, glucose intolerance, age, and antihypertensive medications. The mean increment in summed 1- and 2-h insulin levels (milliunits per liter) compared with nonobese normotensives with normal tolerance was 12 for hypertension alone, 47 for obesity alone, 52 for abnormal tolerance alone, and 124 when all three conditions were present. The prevalence of concentrations (milliequivalents per liter) of erythrocyte Na+ greater than or equal to 7.0, K+ less than 92.5, and plasma K+ greater than or equal to 4.5 in a subsample of 59 individuals with all combinations of abnormal tolerance obesity and hypertension was compared with those in 30 individuals free of these conditions. Altogether, 88.1% of the former vs. 40.0% of the latter group presented at least one of these three markers of internal cation imbalance (P less than 0.001). We conclude that insulin resistance and/or hyperinsulinemia (a) are present in the majority of hypertensives, (b) constitute a common pathophysiologic feature of obesity, glucose intolerance, and hypertension, possibly explaining their ubiquitous association, and (c) may be linked to the increased peripheral vascular resistance of hypertension, which is putatively related to elevated intracellular sodium concentration.

References

    1. Lancet. 1980 Jun 28;1(8183):1373-6
    1. Diabetologia. 1982 Jun;22(6):399-411
    1. Lancet. 1966 Jun 18;1(7451):1336-7
    1. Int J Epidemiol. 1978 Mar;7(1):15-24
    1. Am J Public Health. 1982 Apr;72(4):359-68
    1. Ann Intern Med. 1983 May;98(5 Pt 2):729-34
    1. J Clin Invest. 1983 Jun;71(6):1523-35
    1. Diabetologia. 1982 Dec;23(6):477-84
    1. Lancet. 1983 Apr 2;1(8327):750-3
    1. Hypertension. 1983 May-Jun;5(3):363-7
    1. J Clin Endocrinol Metab. 1982 Apr;54(4):721-4
    1. Lancet. 1983 Jan 1;1(8314-5):1-5
    1. Fed Proc. 1982 Jun;41(8):2387-93
    1. Ann Intern Med. 1983 May;98(5 Pt 2):735-43
    1. J Clin Invest. 1978 Feb;61(2):472-9
    1. Diabetologia. 1983 Nov;25(5):377-81
    1. J Appl Physiol Respir Environ Exerc Physiol. 1979 Feb;46(2):235-9
    1. Am J Epidemiol. 1976 Feb;103(2):226-35
    1. Int J Obes. 1981;5 suppl 1:143-50
    1. Diabetes Care. 1979 Mar-Apr;2(2):154-60
    1. Diabetologia. 1981 Sep;21(3):165-71
    1. Lancet. 1982 Dec 11;2(8311):1293-5
    1. Am J Clin Nutr. 1982 Nov;36(5):873-7
    1. Am J Physiol. 1959 Jul;197(1):52-4
    1. Am J Physiol. 1980 May;238(5):E421-7
    1. Metabolism. 1980 May;29(5):445-54
    1. Lancet. 1980 Dec 6;2(8206):1207-10
    1. Lancet. 1973 Apr 14;1(7807):794-7
    1. Br Med J. 1976 Jun 5;1(6022):1368-71
    1. Am J Epidemiol. 1984 Mar;119(3):431-44
    1. Lancet. 1982 Oct 23;2(8304):891-4
    1. Clin Endocrinol Metab. 1983 Mar;12(1):191-219
    1. Circulation. 1978 Jul;58(1):3-19
    1. Mt Sinai J Med. 1982 May-Jun;49(3):223-6
    1. Diabetes Care. 1979 Mar-Apr;2(2):131-41
    1. Am J Physiol. 1982 Jul;243(1):E15-30
    1. Am J Epidemiol. 1981 Mar;113(3):276-84
    1. J Clin Invest. 1964 May;43:950-62
    1. Metabolism. 1978 May;27(5):521-4
    1. Br Med J. 1977 Nov 19;2(6098):1307-14
    1. Am J Epidemiol. 1983 Mar;117(3):245-57
    1. J Chronic Dis. 1974 Mar;27(3):103-14
    1. Am J Epidemiol. 1982 Dec;116(6):971-80
    1. Circulation. 1969 Mar;39(3):403-21
    1. Am J Clin Nutr. 1982 Nov;36(5):890-6
    1. Circulation. 1983 Jul;68(1):17-22
    1. Annu Rev Med. 1983;34:145-60
    1. Clin Chim Acta. 1982 Apr 8;120(2):243-50
    1. Diabetologia. 1980 Sep;19(3):205-10
    1. N Engl J Med. 1983 Dec 8;309(23):1450-1
    1. N Engl J Med. 1980 Oct 30;303(18):1017-22
    1. Ann Intern Med. 1983 May;98(5 Pt 2):753-7
    1. Surgery. 1982 Aug;92(2):235-40
    1. Medicine (Baltimore). 1982 May;61(3):125-40
    1. Ann Intern Med. 1983 May;98(5 Pt 2):875-80
    1. Am J Epidemiol. 1981 Apr;113(4):347-56
    1. Dis Mon. 1979 Oct;26(1):1-85
    1. Metabolism. 1981 Jun;30(6):578-82
    1. N Engl J Med. 1978 Sep 7;299(10):525-32
    1. Am J Epidemiol. 1978 Sep;108(3):161-75
    1. Ann Intern Med. 1983 May;98(5 Pt 2):720-3
    1. Biochim Biophys Acta. 1983 Mar 21;737(1):1-49
    1. Diabetes Care. 1981 Jul-Aug;4(4):493-501
    1. Arch Intern Med. 1975 Jun;135(6):811-7
    1. N Engl J Med. 1978 Jan 5;298(1):1-6
    1. Am J Epidemiol. 1981 Nov;114(5):697-704
    1. J Biol Chem. 1982 Jun 25;257(12):6978-86

Source: PubMed

3
Subscribe